Resveratrol suppresses the STAT3 signaling pathway and inhibits proliferation of high glucose-exposed HepG2 cells partly through SIRT1

Oncology Reports

Volumn 30, Issue 6, 2013, Pages 2820-2828

  Li, Yongguang ^a   Zhu, Wei ^a   Li, Jingbo ^a   Liu, Mingya ^a   Wei, Meng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Hyperglycemia; Proliferation; Resveratrol; SIRT1; STAT3

Indexed keywords

CYCLIN B1; CYCLIN D1; GELATINASE B; GLUCOSE; PROTEIN KINASE B; RESVERATROL; SIRTUIN 1; STAT3 PROTEIN; TETRAZOLIUM; VASCULOTROPIN;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CELL SURVIVAL; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SIRTUIN 1; STAT3 TRANSCRIPTION FACTOR; STILBENES;

EID: 84892374743     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2748     Document Type: Article

References (27)

1. El-Serag HB, Hampel H and Javadi F: The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 4: 369-380, 2006.
2. Zheng M, Chen R, Zhong H, et al: Side-effects of resveratrol in HepG2 cells: reduced pten and increased bcl-xl mRNA expression. Mol Med Rep 6: 1367-1370, 2012.
3. Bhardwaj A, Sethi G, Vadhan-Raj S, et al: Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 109: 2293-2302, 2007.
4. Capiralla H, Vingtdeux V, Venkatesh J, et al: Identification of potent small-molecule inhibitors of STAT3 with anti-inflammatory properties in RAW 264.7 macrophages. FEBS J 279: 3791-3799, 2012.
5. Haghikia A, Stapel B, Hoch M and Hilfiker-Kleiner D: STAT3 and cardiac remodeling. Heart Fail Rev 16: 35-47, 2011.
6. Wen S, Li H, Wu ML, et al: Inhibition of NF-κB signaling commits resveratrol-treated medulloblastoma cells to apoptosis without neuronal differentiation. J Neurooncol 104: 169-177, 2011.
7. Cho IR, Koh SS, Malilas W, et al: SIRT1 inhibits proliferation of pancreatic cancer cells expressing pancreatic adenocarcinoma up-regulated factor (PAUF), a novel oncogene, by suppression of â-catenin. Biochem Biophys Res Commun 423: 270-275, 2012.
8. Kim YJ, Hwang SH, Lee SY, et al: miR-486-5p induces replicative senescence of human adipose tissue-derived mesenchymal stem cells and its expression is controlled by high glucose. Stem Cells Dev 21: 1749-1760, 2012.
9. Nie Y, Erion DM, Yuan Z, et al: STAT3 inhibition of gluconeogenesis is downregulated by SirT1. Nat Cell Biol 11: 492-500, 2009.
10. Li T, Wang W, Chen H, Li T and Ye L: Evaluation of antileukemia effect of resveratrol by modulating STAT3 signaling. Int Immunopharmacol 10: 18-25, 2010.
11. Pawlus MR, Wang L and Hu CJ: STAT3 and HIF1alpha cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells. Oncogene: Apr 22, 2013 (Epub ahead of print).
12. Li J, Cui G, Sun L, et al: STAT3 acetylation-induced promoter methylation is associated with downregulation of the ARHI tumor-suppressor gene in ovarian cancer. Oncol Rep 30: 165-170, 2013.
13. Absood A, Hu B, Bassily N and Colletti L: VIP inhibits human HepG2 cell proliferation in vitro. Regul Pept 146: 285-292, 2008.
14. Baur JA and Sinclair DA: Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5: 493-506, 2006.
15. Athar M, Back JH, Tang X, et al: Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 224: 274-283, 2007.
16. Kotha A, Sekharam M, Cilenti L, et al: Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein. Mol Cancer Ther 5: 621-629, 2006.
17. Yu LJ, Wu ML, Li H, et al: Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells. Neoplasia 10: 736-744, 2008.
18. Giraud AS, Menheniott TR and Judd LM: Targeting STAT3 in gastric cancer. Expert Opin Ther Targets 16: 889-901, 2012.
19. Deng J, Liu Y, Lee H, et al: S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. Cancer Cell 21: 642-654, 2012.
20. Tkach M, Coria L, Rosemblit C, et al: Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells. J Immunol 189: 1162-1172, 2012.
21. Sen M, Joyce S, Panahandeh M, et al: Targeting Stat3 abrogates EGFR inhibitor resistance in cancer. Clin Cancer Res 18: 4986-4996, 2012.
22. Yang CL, Liu YY, Ma YG, et al: Curcumin blocks small cell lung cancer cell migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway. PLoS One 7: e37960, 2012.
23. Frye RA: Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun 273: 793-798, 2000.
24. Chang KT and Min KT: Regulation of lifespan by histone deacetylase. Ageing Res Rev 1: 313-326, 2002.
25. Sestito R, Madonna S, Scarponi C, et al: STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation. FASEB J 25: 916-927, 2011.
26. Bernier M, Paul RK, Martin-Montalvo A, et al: Negative regulation of STAT3 protein-mediated cellular respiration by SIRT1 protein. J Biol Chem 286: 19270-19279, 2011.
27. Chen X, Cao Y, Lv D, Zhu Z, Zhang J and Chai Y: Comprehensive two-dimensional HepG2/cell membrane chromatography/ monolithic column/time-of-flight mass spectrometry system for screening anti-tumor components from herbal medicines. J Chromatogr A 1242: 67-74, 2012.